Lam Research Corporation (LRCX) Financial Statements
Lam Research Corporation (LRCX) reported trailing twelve-month revenue of $26.1B (up 33.4% year on year) and net income of $8.4B as of 2026-09-27, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $6.5B.
Source: SEC EDGAR filings · figures as of 2026-09-27 · read by EquiReason
LRCXLam Research CorporationFollow LRCX — free
—
Price chart with a free account
- Market cap
- 287.4B
- P/E TTM
- 34.3
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 26 Jan, in 94 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2011 Jun 11 | FY2012 Jun 12 | FY2013 Jun 13 | FY2014 Jun 14 | FY2015 Jun 15 | FY2016 Jun 16 | FY2017 Jun 17 | FY2018 Jun 18 | FY2019 Jun 19 | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.24 | 2.67 | 3.60 | 4.61 | 5.26 | 5.89 | 8.01 | 11.08 | 9.65 | 10.04 | 14.63 | 17.23 | 17.43 | 14.91 | 18.44 | 23.23 | 26.13 | |
| Gross profit | 1.50 | 1.08 | 1.40 | 2.01 | 2.28 | 2.62 | 3.60 | 5.17 | 4.36 | 4.61 | 6.81 | 7.87 | 7.78 | 7.05 | 8.98 | 11.73 | 13.34 | |
| Research & development | 0.37 | 0.44 | 0.68 | 0.72 | 0.83 | 0.91 | 1.03 | 1.19 | 1.19 | 1.25 | 1.49 | 1.60 | 1.73 | 1.90 | 2.10 | 2.38 | 2.47 | |
| Operating income | 0.80 | 0.24 | 0.12 | 0.68 | 0.79 | 1.07 | 1.90 | 3.21 | 2.46 | 2.67 | 4.48 | 5.38 | 5.17 | 4.26 | 5.90 | 8.20 | 9.65 | |
| Pre-tax income | 0.80 | 0.20 | 0.07 | 0.72 | 0.74 | 0.96 | 1.81 | 3.15 | 2.45 | 2.57 | 4.37 | 5.19 | 5.11 | 4.36 | 5.96 | 8.26 | 9.72 | |
| Income tax | 0.08 | 0.04 | -0.05 | 0.09 | 0.09 | 0.05 | 0.11 | 0.77 | 0.26 | 0.32 | 0.46 | 0.59 | 0.60 | 0.53 | 0.60 | 1.00 | 1.27 | |
| Net income | 0.72 | 0.17 | 0.11 | 0.63 | 0.66 | 0.91 | 1.70 | 2.38 | 2.19 | 2.25 | 3.91 | 4.61 | 4.51 | 3.83 | 5.36 | 7.27 | 8.45 | |
| Diluted EPS ($) | 5.79 | 1.35 | 0.66 | 3.62 | 3.70 | 5.22 | 9.24 | 13.17 | 13.70 | 15.10 | 26.90 | 32.75 | 3.32 | 2.90 | 4.15 | 5.76 | 6.71 | |
| Diluted shares (bn) | 0.125 | 0.125 | 0.173 | 0.175 | 0.177 | 0.175 | 0.184 | 0.181 | 0.160 | 0.149 | 0.145 | 0.141 | 1.358 | 1.320 | 1.290 | 1.261 | — |
USD billions · SEC XBRL
Lam Research Corporation — questions
- What is Lam Research Corporation's revenue?
- $26.1B over the twelve months to 2026-09-27, up 33.4% year on year, from its 10-Q and 10-K filings.
- What is Lam Research Corporation's net income?
- $8.4B over the twelve months to 2026-09-27.
- What is Lam Research Corporation's free cash flow?
- $6.5B over the twelve months to 2026-09-27.
- What are Lam Research Corporation's diluted earnings per share?
- $6.71 over the twelve months to 2026-09-27.
Every figure on this page comes from Lam Research Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.